Skip to content

NanoKnife 20400109Recalls & reported problems

Angiodynamics, Inc. · NanoKnife Disposable Single Electrode Probe · Class 2

All models of NanoKnife (9)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI H787204001090), received between Sep 9, 2020 and Sep 17, 2025 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Arcing” (1 report).

1 other recall cover devices cleared under the same FDA submission (K183385); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Arcing1

Patient problems

  • Fistula1
  • Fluid Discharge1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 17, 2025Arcing; Arcing

    AN ANGIODYNAMICS TERRITORY MANAGER REPORTED AN ISSUE WITH A 15 CM IRE SINGLE ACTIVATION ELECTRODE. DURING THE 3RD ABLATION OF A DESMOID TREATMENT, ONE PROBE STARTED ARCING, PAST THE SKIN, WHILE STILL INSERTED IN THE PATIENT. THE PREVIOUS 2 ABLATIONS DONE WITH THIS DEVICE WERE SUCCESSFUL WITH NO ISSUES. THIS ONLY OCCURRED WHILE THAT PROBE WAS IN ACTIVE USE, AND WAS QUICKLY SHUT DOWN AFTER JUST A FEW PULSES. THE PHYSICIAN THEN REMOVED THAT PROBE AND COMPLETED THE ABLATION WITH THE UNAFFECTED PROBES. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS, HARM, OR REQUIRE MEDICAL INTERVENTION BECAUSE OF THIS INCIDENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23076478 ↗
  • InjuryJun 4, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A GLOBAL SCIENTIFIC AND CLINICAL AFFAIRS MANAGER REPORTED AN PATIENT EXPERIENCED AN ISSUE POST PROCEDURE ASSOCIATED WITH THE USE OF A NANOKNIFE PROBE. ON (B)(6) 2024 PATIENT RECEIVED AN IRE TREATMENT TO RIGHT ANTERIOR TRANSITION ZONE OF PROSTATE. PATIENT DEVELOPED PELVIC PAIN AND URINARY RETENTION WEEK AFTER AND WENT TO ER. CT SCAN COMPLETED AND SUSPECT URETHRORECTAL FISTULA NOTED. URINARY CATHETER LEFT IN PLACE AND PATIENT ON ANTIBIOTICS. PATIENT BEING SCHEDULED FOR MPMRI IN NEXT COUPLE WEEKS FOR DEFINITIVE DIAGNOSIS. ADDITIONAL INFORMATION: RECEIVED A CLINICAL UPDATE FROM DR. ROTHBERG ON THURSDAY MAY 23RD. PATIENT RECEIVED FOLEY CATHETER INSERTIONS POST PROCEDURE IN ER AS WELL AS UROLOGY CLINIC. SPECIFIC DATES NOT PROVIDED. CYSTOSCOPY COMPLETED ON THURSDAY MAY 23RD FOR ASSESSMENT. FISTULA NOTED DISTAL TO IRE ABLATION AREA. PRESUMED FISTULA FROM TRAUMATIC FOLEY CATHETER INSERTION POST IRE TREATMENT.

    Patient problems: Fistula

    MAUDE report 19457749 ↗
  • InjurySep 9, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THIS MEDWATCH IS NOT TO REPORT A DEVICE MALFUNCTION, BUT TO REPORT AN ADVERSE PATIENT EFFECT. AN ANGIODYNAMICS TERRITORY MANAGER REPORTED AN ISSUE THAT OCCURRED DUE TO A NANOKNIFE TREATMENT. POST PROCEDURE, THE PATIENT STARTED HAVING NAUSEA/VOMITING & INCREASING WBC COUNT SO A CT SCAN WAS PERFORMED. THE SCAN INDICATED THE PATIENT WAS EXPERIENCING A PANCREATIC DUCT LEAK AFTER TREATMENT. A SECOND DRAIN WAS PLACED TO DRAIN THE POOL OF PANCREATIC FLUID. IT WAS REPORTED THAT IS PATIENT IS OKAY. THE REPORTED DEVICE HAS BEEN RETURNED TO THE MANUFACTURER AND AN INVESTIGATION INTO THE ROOT CAUSE FOR EVENT IS CURRENTLY IN PROGRESS.

    Patient problems: Fluid Discharge

    MAUDE report 10507152 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K183385. One submission often covers many models, so check the product and lot details in each record.

  • Z-1381-2023 · Mar 2, 2023 · Open, Classified
    NanoKnife 5-Probe Procedure Pack 15 cm - Activation. Indicated for the surgical ablation of soft tissue. Catalog Number: 20400111 UPN: H787204001110

Other Low energy direct current thermal ablation system devices

All Low energy direct current thermal ablation system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page